## MCK: McKesson Corporation - XLV: Healthcare

### Executive Summary

VALUE thesis: PEG 0.98 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($777.42)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 7, Bearish: 0)

**1. WINTON GROUP Ltd Makes New $1.33 Million Investment in McKesson Corporation $MCK**
- Source: MarketBeat | 20251212T130835 | Bullish | Relevance: 100%
- WINTON GROUP Ltd has acquired a new stake of 1,814 shares in McKesson Corporation, valued at approximately $1.33 million as of Q2. McKesson's stock (NYSE:MCK) has a "Moderate Buy" consensus rating from analysts with an average price target of $892.86. The company recently reported strong quarterly earnings, exceeding EPS expectations, and declared a quarterly dividend of $0.82 per share.

**2. Westwood Holdings Group Inc. Boosts Stock Position in McKesson Corporation $MCK**
- Source: MarketBeat | 20251215T140627 | Somewhat-Bullish | Relevance: 100%
- Westwood Holdings Group Inc. significantly increased its stake in McKesson Corporation (NYSE:MCK) by 778.7% in the second quarter, now owning 53,690 shares valued at $39.34 million. Other institutional investors also adjusted their positions, and McKesson recently announced a quarterly dividend of $0.82 per share. Analyst ratings for MCK are generally positive, with a "Moderate Buy" consensus and an average price target of $892.86.

**3. Medication Management Market Is Going to Boom |• McKesson Corporation • Cardinal Health**
- Source: openPR.com | 20251215T110038 | Bullish | Relevance: 100%
- Worldwide Market Reports (WMR) projects substantial growth for the Medication Management Market, offering a comprehensive analysis that includes market dynamics, growth drivers, restraints, challenges, opportunities, and competitive landscapes. The report covers key market players like McKesson Corporation and Cardinal Health, along with segmental highlights by types and applications, and provides regional outlooks. It utilizes extensive primary and secondary research to deliver actionable intelligence and growth forecasts for the market from 2025 to 2032.

**4. McKesson Corporation $MCK Shares Sold by National Bank of Canada FI**
- Source: MarketBeat | 20251215T102438 | Bullish | Relevance: 100%
- National Bank of Canada FI significantly reduced its stake in McKesson Corporation, selling 40.6% of its shares. Despite this, analysts maintain a "Moderate Buy" rating with a consensus price target of $892.86. McKesson recently surpassed EPS expectations, announced a quarterly dividend of $0.82, and continues to attract institutional investment.

**5. Advisory Services Network LLC Grows Holdings in McKesson Corporation $MCK**
- Source: MarketBeat | 20251215T081317 | Bullish | Relevance: 100%
- Advisory Services Network LLC increased its stake in McKesson Corporation by 11.9% in Q2, bringing its total to 15,052 shares valued at $10.44 million. Other institutions also significantly boosted their holdings, with Norges Bank acquiring a new $1.35 billion stake. Analysts maintain a "Moderate Buy" rating for MCK, with an average price target of $892.86.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Barclays | $960 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Barclays | init | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 1 ($0.28M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.8% (-0.3%)
- Blackrock Inc.: 9.2% (+0.4%)
- State Street Corpora: 4.7% (+0.9%)
- JPMORGAN CHASE & CO: 4.5% (+16.0%)
- Massachusetts Financ: 3.2% (-1.5%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.98 indicates undervaluation relative to growth. Balance sheet: $2.3B free cash flow. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $101.2B |
| Beta | 0.38 |
| 52W Range | $558.13 - $895.58 |
| Short Interest | 1.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.98 |
| Forward P/E | 18.6 |
| Current P/E | 21.0 |
| YoY Growth | 13.3% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -7.9% to -3.5% (+4.3% in 5 days), confirming momentum buildup. Below STRENGTH zone by 7.5pp (needs >4.0% for momentum thesis). MRS_5 turning positive (2.2%) - potential reversal signal. AM_20 at -3.1% indicates price below own 20MA trend. Underperforming sector by 3.3pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.12x) but short-term weakness (below SMA20). MACD histogram bearish (-6.78), momentum weakening. RSI neutral at 45. OFD pattern: -SUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -3.54% (CS: 13) | Weak |
| RSI_14 | 45.0 | Neutral |
| MACD Histogram | -6.78 | Bearish |
| vs SMA20 | 0.969x | Below |
| vs SMA50 | 0.996x | Below |
| vs SMA200 | 1.118x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $813.80
- **Stop Loss:** $777.42 (4.5% risk)
- **Target:** $886.56 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 27
- **Position Value:** $21,972.60
- **Portfolio %:** 21.97%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX remains calm at 15.74 while breadth shows modest participation at 54%, suggesting selective positioning. FOMC meeting in 4 days creates near-term uncertainty but no systemic stress evident.*

### Earnings

**Next:** 2026-02-04 (Est: $9.28)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $9.05 | $9.86 | +8.9% |
| 2025Q2 | $8.15 | $8.26 | +1.4% |
| 2025Q1 | $9.83 | $10.12 | +3.0% |
| 2024Q4 | $7.99 | $8.03 | +0.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*